12:00 AM
 | 
Feb 11, 2013
 |  BC Week In Review  |  Financial News  |  Other Financial News

Myriad Genetics financial update

Myriad Genetics said its board authorized a $200 million share repurchase program. The company also said it repurchased...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >